JFL Life Sciences IPO description – The company is engaged in the business of manufacturing and sales of pharmaceutical products in domestic as well as international business. Products of JFL is supplied to 10 developed and developing countries throughout the World. To maintain its competitiveness and to further the cause of health care, JFL has laid a strong R&D foundation and an FDA approved state of the art manufacturing facility near Ahmedabad.
JFL Life Sciences’ sales strategy is to sell its products in bulk to pharmaceuticals marketers and traders who in turn provide the channel for sales to customers. The company does not sell it under any brand name and uses the same strategy for both domestic & international market. Following are its major products:
- Dry powder injections
- Tablets & Capsules (B-Lactam) solid oral dosage form.
- Tablet and capsules (General)
- Oral Rehydration Solutions (ORS)
The company exports its products to African countries, Middle Eastern countries and CIS countries, mainly through merchant exporters. The company is registered with the MOH of Kenya, Nigeria, Yemen, Cambodia & Myanmar for manufacturing of a particular product. Few of its products are also registered with Ukraine, Uzbekistan, Kazakhstan (CIS countries) through merchants. As on 28 February 2022, its domestic sales comprise of 23.02% while the export sales comprise of 76.98%.
Promoters of JFL Life Sciences Limited – Smiral Ashwinkumar Patel and Tejal Smiral Patel
JFL Life Sciences IPO Details
| Subscription Dates | 25 – 30 August 2022 |
| Price Band | INR 61 per share |
| Fresh issue | 29,78,000 shares (INR 18.17 crore) |
| Offer For Sale | Nil |
| Total IPO size | 29,78,000 shares (INR 18.17 crore) |
| Minimum bid (lot size) | 2,000 shares |
| Face Value | INR 10 per share |
| Retail Allocation | 50% |
| Listing On | NSE Emerge |
JFL Life Sciences Financial Performance
| Â | FY2019 | FY2020 | FY2021 | 11M FY2022 |
| Revenue | 3,177.96 | 3,020.41 | 3,286.89 | 2,563.06 |
| Expenses | 3,135.68 | 2,970.71 | 3,212.23 | 2,222.05 |
| Net income | 30.25 | 36.04 | 54.21 | 253.28 |
JFL Life Sciences Offer News
JFL Life Sciences Valuations & Margins
| FY2019 | FY2020 | FY2021 | 11M FY2022 | |
| EPS | 0.59 | 0.66 | 0.89 | 3.77 |
| PE ratio | – | – | 68.54 | 16.18 |
| RONW (%) | 6.03 | 6.70 | 7.89 | 25.20 |
| EBITDA (%) | 4.16 | 6.28 | 6.86 | 20.63 |
| NAV | – | – | 138.29 | 13.67 |
JFL Life Sciences IPO GMP Daily Trend
| Date | JFL Life Sciences IPO GMP | Kostak | Subject to Sauda |
| 7 Sep 2022 | 3 | – | 8,000 |
| 6 Sep 2022 | 5 | – | 10,000 |
| 5 Sep 2022 | 5 | – | 10,000 |
| 2 Sep 2022 | 5 | – | 12,000 |
| 1 Sep 2022 | 4 | – | 12,000 |
| 30 Aug 2022 | 5 | – | 15,000 |
| 29 Aug 2022 | 5 | – | 15,000 |
| 27 Aug 2022 | 5 | – | 17,000 |
| 26 Aug 2022 | 5 | – | 17,000 |
| 25 Aug 2022 | 5 | – | 15,000 |
| 24 Aug 2022 | 7 | – | 15,000 |
| 23 Aug 2022 | 7 | – | 13,000 |
| 22 Aug 2022 | 5 | – | 10,000 |
| 20 Aug 2022 | 5 | – | 8,000 |
| 19 Aug 2022 | 5 | – | 8,000 |
JFL Life Sciences IPO Subscription – Live Updates
| Category | Non-retail | Retail | Total |
| Shares Offered | 14,89,000 | 14,89,000 | 29,78,000 |
| Day 1 | 0.23 | 0.71 | 0.47 |
| Day 2 | 0.49 | 1.56 | 1.02 |
| Day 3 | 0.62 | 3.53 | 2.08 |
| Day 4 | 5.88 | 11.07 | 8.48 |
JFL Life Sciences IPO Lead Manager
GYR Capital Advisors Private Limited
428, Gala Empire, Near JB Tower,
Drive in Road, Thaltej,
Ahmedabad -380 054, Gujarat
Phone : +91 87775 64648
E-mail:Â [email protected]
Website: www.gyrcapitaladvisors.com
JFL Life Sciences Offer Registrar
KFin Technologies Limited
Selenium Tower-B, Plot 31 & 32,
Gachibowli, Financial District,
Nanakramguda, Serilingampally,
Hyderabad – 500 032, Telangana
Phone: +91 40 6716 2222
Fax: +91 40 2343 1551
Email: [email protected]
Website: www.kfintech.com
JFL Life Sciences IPO Contact Details
JFL Life Sciences Limited
309, Satyam Mall, Opp. Saman Complex,
Nr. Vishweshwar Mahadev Mandir,
Settelite, Ahmedabad-380015, Gujarat
Phone: +91-93772-95575
E-mail: [email protected];
Website: www.jfllifesciences.com
JFL Life Sciences IPO Allotment Status
JFL Life Sciences IPO allotment is now available on KFin Technologies’ website. Click on this link to get allotment status.
JFL Life Sciences IPO Timetable
| IPO Opening Date | 25 August 2022 |
| IPO Closing Date | 31 August 2022 |
| Finalisation of Basis of Allotment | 5 September 2022 |
| Initiation of refunds | 6 September 2022 |
| Transfer of shares to demat accounts | 7 September 2022 |
| Listing Date | 8 September 2022 |
| Opening Price on NSE SME | INR70 per share (up 14.75% from IPO price) |
| Closing Price on NSE SME | Coming soon |
JFL Life Sciences IPO FAQs
What is JFL Life Sciences offer size?
JFL Life Sciences offer size is INR18.17 crore.
What is JFL Life Sciences IPO Price Band?
JFL Life Sciences public offer price is INR 61 per share.
What is the lot size of JFL Life Sciences IPO?
JFL Life Sciences offer lot size is 2,000 shares.
What is JFL Life Sciences IPO GMP today?
JFL Life Sciences IPO GMP today is INR3 per share.
What is JFL Life Sciences kostak rate today?
JFL Life Sciences kostak rate today is NA per application.
What is JFL Life Sciences Subject to Sauda rate today?
JFL Life Sciences Subject to Sauda rate today is INR8,000 per application.
JFL lifescience NAV is given wrong if compared with RHP of company,